The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses

被引:30
|
作者
Wei, X
Liang, C
Götte, M
Wainberg, MA
机构
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Expt Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada
关键词
HIV-1 reverse transcriptase; initiation; tRNA(Lys3); M184V;
D O I
10.1097/00002030-200212060-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To study the ability of HIV constructs containing the M184V substitution in reverse transcriptase (RT), which causes resistance to lamivudine, to evolve mutations that compensate for deletions within the HIV genome. Methods: Viruses containing deletions in non-coding regions of the viral genome were examined in tissue culture to see whether the additional presence of M184V delays the reestablishment of wild-type replication kinetics. Potential compensatory mutations were identified by sequencing, and site-directed mutagenesis was carried out to confirm the biological relevance of such substitutions. The rate of initiation of reverse transcription was measured using either recombinant wild-type RT or RT containing M184V. Results: M184V-containing viruses were unable to undergo compensatory mutagenesis to reestablish wild-type replication kinetics, whereas viruses that did not contain M184V were able to mutate extensively. This ability was demonstrated most extensively in viruses deleted of an 'A-rich loop', located upstream of the primer-binding site, which is involved in initiation of reverse transcription. The rate of such initiation was severely diminished in virus containing the RT enzyme carrying the M184V substitution. This inhibitory effect was significantly enhanced in a biochemical system that included both the M184V mutant enzyme and a viral DNA template that contained the deletion in the A-rich loop. Conclusions: These findings provide further biological and biochemical evidence that M184V-containing viruses are impaired in replication fitness. Viruses that had the A-rich-loop deleted were able to reestablish replication ability quickly in the wild-type RT, which provides further evidence for the plasticity of the HIV genome. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:2391 / 2398
页数:8
相关论文
共 50 条
  • [21] Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir
    Byun, Hyeonah
    Papathanasopoulos, Maria Antonia
    Steegen, Kim
    Basson, Adriaan Erasmus
    VIRUSES-BASEL, 2024, 16 (12):
  • [22] Rationale for maintenance of the M184V resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients
    Turner, D
    Brenner, BG
    Routy, JP
    Petrella, M
    Wainberg, MA
    MICROBIOLOGICA, 2004, 27 (02): : 31 - 39
  • [23] Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase
    Quan, YD
    Motakis, D
    Buckheit, R
    Xu, ZQ
    Flavin, MT
    Parniak, MA
    Wainberg, MA
    ANTIVIRAL THERAPY, 1999, 4 (04) : 203 - 209
  • [24] Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead
    Ippolito, Joseph A.
    Niu, Haichan
    Bertoletti, Nicole
    Carter, Zachary J.
    Jin, Shengyan
    Spasov, Krasimir A.
    Cisneros, Jose A.
    Valhondo, Margarita
    Cutrona, Kara J.
    Anderson, Karen S.
    Jorgensen, William L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (02): : 249 - 255
  • [25] The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis
    Götte, M
    Arion, D
    Parniak, MA
    Wainberg, MA
    JOURNAL OF VIROLOGY, 2000, 74 (08) : 3579 - 3585
  • [26] The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors
    Miller, V
    Stürmer, M
    Staszewski, S
    Gröschel, B
    Hertogs, K
    de Béthune, MP
    Pauwels, R
    Harrigan, PR
    Bloor, S
    Kemp, SD
    Larder, BA
    AIDS, 1998, 12 (07) : 705 - 712
  • [27] Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1
    Hsu, ML
    Inouye, P
    Rezende, L
    Richard, N
    Li, Z
    Prasad, VR
    Wainberg, MA
    NUCLEIC ACIDS RESEARCH, 1997, 25 (22) : 4532 - 4536
  • [28] Sensitivity of Phenotypic Susceptibility Analyses for Nonthymidine Nucleoside Analogues Conferred by K65R or M184V in Mixtures with Wild-Type HIV-1
    Underwood, Mark R.
    Ross, Lisa L.
    Irlbeck, David M.
    Gerondelis, Peter
    Rouse, Elizabeth
    Clair, Marty H. St.
    Trinh, Lan
    Parkin, Neil
    Lanier, E. Randall
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (01): : 84 - 88
  • [29] Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro
    Miller, MD
    Anton, KE
    Mulato, AS
    Lamy, PD
    Cherrington, JM
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01): : 92 - 100
  • [30] Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1
    Diallo, K
    Oliveira, M
    Moisi, D
    Brenner, B
    Wainberg, MA
    Götte, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2254 - 2256